中通快遞(02057.HK)由紀錄高續吐4.5%曾失20天線 第三季少賺7.4%
9月尾才以每股2.18元來港上市的中概股中通快遞-SW(02057.HK)第三季少賺7.4%,該股繼昨天扭轉連續兩天創上市新高強勢回吐後,今天曾失守10天及20天線(243.3元及237.65元),最低見235.2元獲承接,現造245.4元,續吐4.5%,成交增至57.4萬股,涉資1.41億元。
中通快遞公布,截至9月底止首三季純利按年跌9.7%至30.24億元人民幣(下同),營業額按年升11%至169.57億元。單計第三季,純利按年跌7.4%至12.1億元,營收按年增長26%至66.39億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.